Rhythm Pharmaceuticals
RYTM
RYTM
168 hedge funds and large institutions have $3.08B invested in Rhythm Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 42 increasing their positions, 63 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
17% more funds holding
Funds holding: 143 → 168 (+25)
6.5% less ownership
Funds ownership: 119.74% → 113.24% (-6.5%)
33% less repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 63
Holders
168
Holding in Top 10
10
Calls
$50M
Puts
$3.11M
Top Buyers
| 1 | +$81.5M | |
| 2 | +$53.5M | |
| 3 | +$16.6M | |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
+$15.7M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$14.9M |
Top Sellers
| 1 | -$39.5M | |
| 2 | -$34.5M | |
| 3 | -$27.3M | |
| 4 |
CC
Commodore Capital
New York
|
-$24.1M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$20.4M |